Clinical Trial Update: Clinical Study to Evaluate the Efficacy and Safety of VR506 Using a New Inhaler for the Treatment of Asthma [Phase 2, Phase 3]

View source ↗

Summary

Clinical trial update for VR506 using a new inhaler in asthma, completed phase 2/3 with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• VR506

Snippet

Sponsor: Vectura Limited | Conditions: Asthma | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2020-04-21